This map shows the geographic impact of S Gough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Gough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Gough more than expected).
This network shows the impact of papers produced by S Gough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Gough. The network helps show where S Gough may publish in the future.
Co-authorship network of co-authors of S Gough
This figure shows the co-authorship network connecting the top 25 collaborators of S Gough.
A scholar is included among the top collaborators of S Gough based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S Gough. S Gough is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
16 of 16 papers shown
1.
Hamilton, Alexander, Shruti Mittal, Martin Barnardo, et al.. (2015). Impact of HMOX1 Genetic Variation in Pancreas Transplant Recipients On Long-Term Graft Outcome. American Journal of Transplantation. 15.1 indexed citations
Armstrong, Matthew J., D. Hull, Darren Barton, et al.. (2013). Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial. Hepatology. 58.1 indexed citations
Birkeland, K. I., Itamar Raz, S Gough, et al.. (2011). Insulin degludec in a flexible daily dosing regimen provides similar glycaemic control without increasing rates of hypoglycaemia compared to dosing the same time daily in type 2 diabetes. Diabetologia. 54.6 indexed citations
6.
Atkin, Stephen L., Steve Baín, S Gough, et al.. (2011). Insulin degludec does not compromise efficacy or safety when given in a flexible once-daily dosing regimen compared to insulin glargine once daily at the same time each day in type 2 diabetes. Diabetologia. 54.8 indexed citations
7.
Armstrong, Matthew J., et al.. (2010). High prevalence of advanced NAFLD in type 2 diabetic patients with unremarkable liver enzymes and effect of liraglutide on NAFLD: meta-analysis of the LEAD Program. Diabetologia. 53.1 indexed citations
8.
Armstrong, Matthew J., A Falahati, Oscar Ö. Braun, et al.. (2010). High Prevalence of Advanced NAFLD in Type 2 Diabetic Patients with Normal Liver Enzymes and Effect of Liraglutide on NAFLD: Meta-Analysis of the LEAD Program. Diabetes. 59.4 indexed citations
9.
Zinman, Bernard, John B. Buse, A Falahati, A C Moses, & S Gough. (2009). Liraglutide More Effectively Achieves a Composite Endpoint for A1C, SBP and Weight Change Than Other Diabetes Therapies. Diabetes. 58.8 indexed citations
10.
Gough, S, Kirstine Brown Frandsen, & Anders Toft. (2008). Glycaemic control and cardiovascular risk in insulin-treated patients with type 2 diabetes in Germany and the UK. Diabetologia. 51.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.